Dual effects of L-3,4-dihydroxyphenylalanine on aromatic L-amino acid decarboxylase, dopamine release and motor stimulation in the reserpine-treated rat: evidence that behaviour is dopamine independent

A FisherM S Starr


The comparative effects of L-3,4-dihydroxphenylalanine (L-DOPA) on dopamine synthesis, release and behaviour were studied in the reserpine-treated rat. Acute administration of L-DOPA (25-200 mg/kg) dose-dependently inhibited the activity of aromatic L-amino acid decarboxylase (AADC) in the substantia nigra and corpus striatum. The antiparkinsonian drugs budipine (10 mg/kg) and amantadine (40 mg/kg) enhanced AADC activity in these regions, and prevented or reversed AADC inhibition by L-DOPA. Dual probe dialysis revealed that low doses of L-DOPA (25-50 mg/kg) dose-dependently stimulated the release of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) in nigra and striatum, whilst high doses of L-DOPA (100-200 mg/kg) completely suppressed the release of dopamine, but not DOPAC. Sulpiride (50 microM) administered via the probes antagonized dopamine release in response to 25 mg/kg L-DOPA, but greatly facilitated release by 200 mg/kg L-DOPA. Dopamine release was blocked by the centrally acting AADC inhibitor NSD 1015, but facilitated by the central AADC activator budipine. In behavioural tests L-DOPA (plus benserazide, 50 mg/kg) only reversed akinesia at 200 mg/kg, and not at 25-100 mg/kg. Pretreatment with either NSD 1015 (100 mg/...Continue Reading


Mar 26, 1977·Lancet·M D Yahr
Aug 25, 1978·Brain Research·R C Duvoisin, C Mytilineou
Jun 1, 1991·Brain : a Journal of Neurology·J M TrugmanG F Wooten
Oct 1, 1989·Trends in Neurosciences·R L AlbinJ B Penney
Jun 29, 1988·Neuroscience Letters·G S Robertson, H A Robertson
Jan 16, 1971·Lancet·J Lehmann
Feb 13, 1969·The New England Journal of Medicine·G C CotziasR Gellene
Feb 7, 1970·Lancet·J D ParkesR P Knill-Jones
May 1, 1969·The Journal of Pharmacy and Pharmacology·G BartholiniA Pletscher
Oct 1, 1974·Life Sciences·O Hornykiewicz
Jul 1, 1972·Neurology·L K NgI J Kopin
Jan 1, 1971·Annual Review of Medicine·G C CotziasS Düby
Jan 1, 1972·Activitas Nervosa Superior·I BreznýM Trávniková
Apr 1, 1972·Neurology·T N Chase, A M Watanabe
Sep 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·W DairmanS Udenfriend
Sep 1, 1971·Proceedings of the National Academy of Sciences of the United States of America·S S TateA Meister
Mar 1, 1971·Clinical Pharmacology and Therapeutics·G C CotziasS Düby
May 15, 1971·Life Sciences. Pt. 1: Physiology and Pharmacology·U K RinneM Hyyppä
Dec 1, 1980·Journal of Neuroscience Methods·G PaxinosP C Emson

❮ Previous
Next ❯


Nov 19, 2002·Journal of Neurobiology·Edna F R PereiraEdson X Albuquerque
Nov 9, 2000·European Journal of Pharmacology·N JonkersY Michotte
Feb 1, 2003·Pharmacology & Therapeutics·Yoshimi MisuYoshio Goshima
Mar 29, 2001·Neuroscience·A LopezJ L Labandeira-Garcia
Aug 28, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marco BortolatoJean C Shih
Jul 23, 2009·Neuroreport·Patric K StantonJoseph R Moskal
Sep 2, 2004·Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine·Jian-Cheng HeRu-Xing Chen
Apr 20, 2004·The European Journal of Neuroscience·Magali PeetersEmmanuel Hermans
Jul 9, 2016·Progress in Neurobiology·Philippe De DeurwaerdèreMark J Millan
Dec 2, 2008·CNS Neuroscience & Therapeutics·Maria Hadjiconstantinou, Norton H Neff
Oct 5, 2019·Biomédica : revista del Instituto Nacional de Salud·María Del Pilar OlayaMario Francisco Guerrero
Mar 5, 2003·Journal of Neurochemistry·Christian E GrossErwan Bezard
Dec 10, 2016·Frontiers in Neuroscience·Giuseppe Di GiovanniPhilippe De Deurwaerdère
Aug 25, 2017·Evidence-based Complementary and Alternative Medicine : ECAM·Luiz Eduardo Mateus BrandãoAlessandra Mussi Ribeiro
Jan 26, 2010·Neurobiology of Disease·Sylvia NavaillesPhilippe De Deurwaerdère

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.